We are live on ! Find out more
DS

David Shaw D.E. Shaw & Co

AUM $210B
1-Year Est. Return 57.28%
 

David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.

This Fund
S&P 500
This Quarter Est. Return
+14.94%
1 Year Est. Return
+57.28%
3 Year Est. Return
+174.65%
5 Year Est. Return
+213.13%
10 Year Est. Return
+910.08%
AUM
$114B
AUM Growth
+$18.7B
Cap. Flow
+$1.27B
Cap. Flow %
1.11%
Top 10 Hldgs %
12.43%
Holding
4,806
New
575
Increased
1,549
Reduced
1,464
Closed
527

Sector Composition

Rank Sector Weight
1 Technology 17.03%
2 Consumer Discretionary 9.51%
3 Healthcare 5.77%
4 Financials 5.47%
5 Communication Services 4.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LAD icon
1276
PUT
Lithia Motors
LAD
$8.1B
$9.68M 0.01%
29,400
-1,500
-5% -$412K
PEG icon
1277
Public Service Enterprise Group
PEG
$36.6B
$9.68M 0.01%
158,272
+125,418
+382% +$7.71M
GGAL icon
1278
Galicia Financial Group
GGAL
$6.98B
$9.67M 0.01%
559,865
+2,063
+0.4% +$29.2K
INFN
1279
DELISTED
Infinera Corporation Common Stock
INFN
$9.65M 0.01%
2,031,937
-911,216
-31% -$3.58M
ALC icon
1280
Alcon
ALC
$35.6B
$9.65M 0.01%
123,478
+35,411
+40% +$2.62M
UGI icon
1281
UGI
UGI
$8.19B
$9.6M 0.01%
390,420
-644,477
-62% -$14.2M
MRVL icon
1282
Marvell Technology
MRVL
$206B
$9.6M 0.01%
159,204
-310,163
-66% -$16.8M
DOW icon
1283
CALL
Dow Inc
DOW
$22.7B
$9.6M 0.01%
175,000
-40,000
-19% -$2.04M
ATS icon
1284
ATS Corp
ATS
$1.89B
$9.57M 0.01%
222,200
+51,300
+30% +$1.99M
TNC icon
1285
Tennant Co
TNC
$1.16B
$9.57M 0.01%
103,286
+30,741
+42% +$2.55M
TBPH icon
1286
Theravance Biopharma
TBPH
$883M
$9.57M 0.01%
851,208
+161,647
+23% +$1.63M
ROG icon
1287
Rogers Corp
ROG
$2.19B
$9.57M 0.01%
72,425
-18,580
-20% -$2.38M
DAY
1288
DELISTED
Dayforce
DAY
$9.56M 0.01%
142,480
+130,761
+1,116% +$8.93M
HXL icon
1289
Hexcel
HXL
$7B
$9.55M 0.01%
129,429
+1,636
+1% +$111K
CB icon
1290
Chubb
CB
$133B
$9.52M 0.01%
42,108
-87,733
-68% -$19.2M
SONY icon
1291
PUT
Sony
SONY
$142B
$9.47M 0.01%
500,000
AIG icon
1292
CALL
American International
AIG
$40.5B
$9.44M 0.01%
139,300
+66,500
+91% +$4.24M
TBI
1293
Trueblue
TBI
$325M
$9.41M 0.01%
613,300
+238,905
+64% +$3.34M
ENVA icon
1294
Enova International
ENVA
$6.17B
$9.38M 0.01%
169,379
+97,409
+135% +$4.5M
MAA icon
1295
Mid-America Apartment Communities
MAA
$15.4B
$9.37M 0.01%
69,666
+14,945
+27% +$1.9M
PBI icon
1296
Pitney Bowes
PBI
$2.27B
$9.37M 0.01%
2,128,431
-504,945
-19% -$1.96M
GT icon
1297
PUT
Goodyear
GT
$1.73B
$9.35M 0.01%
653,200
+100,000
+18% +$1.33M
VRE
1298
DELISTED
Veris Residential
VRE
$9.35M 0.01%
594,294
-212,729
-26% -$3.17M
RRR icon
1299
Red Rock Resorts
RRR
$3.59B
$9.33M 0.01%
175,014
-97,721
-36% -$4.34M
NVO
1300
PUT
Novo Nordisk
NVO
$207B
$9.31M 0.01%
90,000
+13,000
+17% +$1.29M

Similar funds

David Shaw's Q4 2023 Portfolio in Review

As of Q4 2023, David Shaw held 4,806 positions worth $114B, up 19% from $95.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

David Shaw's Q4 2023 filing shows 575 new, 1,549 increased, 1,464 reduced and 527 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $546M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • David Shaw's largest Q4 2023 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M.
  • David Shaw added most to Netflix in Q4 2023, an estimated $751M increase.
  • David Shaw's biggest Q4 2023 reduction was Microsoft, cutting an estimated $336M.
  • David Shaw fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $546M.
  • David Shaw's ten largest holdings make up 12% of its $114B portfolio in Q4 2023.
  • David Shaw opened 575 new positions and closed 527 in Q4 2023.
  • David Shaw's portfolio value rose 19% quarter-over-quarter to $114B.

Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.